Monthly Archives: October 2026


Exercise Prescription: A Core Component of CVD Prevention and Treatment

An American College of Cardiology scientific statement emphasizes that exercise should be prescribed as a core component of cardiovascular disease (CVD) prevention and management, with the greatest absolute benefits occurring when physically inactive individuals begin exercising. The statement provides practical guidance for tailoring aerobic, resistance, balance, and flexibility training to […]


Low-Fat Vegan Diet Improves Metabolic Health in T2D

A 16-week low-fat vegan diet was associated with significant reductions in body weight, visceral fat, liver fat, and advanced glycation end products (AGEs), alongside improved insulin sensitivity and beta-cell function in adults with type 2 diabetes (T2D). In this US study of 25 participants, mean body weight decreased by 6.0 […]


Lipid-Rich Plaques That May Benefit From Preventive PCI

Preventive PCI was associated with a substantially lower risk of major cardiac events in patients with near-infrared spectroscopy–defined lipid-rich plaques (LRPs), but not in those without LRPs, suggesting that plaque composition may be more informative than plaque size alone in selecting lesions for preventive treatment. In this post hoc analysis […]


Heart-Healthy Eating: Focus on the Overall Dietary Pattern

A healthy, balanced dietary pattern—not an emphasis on individual nutrients or foods—is central to preventing and managing cardiovascular and cardiometabolic disease, according to a new American College of Cardiology Scientific Statement. The statement reviews evidence on macronutrients, micronutrients, dietary patterns, ultra-processed foods, and emerging nutrition-based interventions, emphasizing that heart-healthy eating […]


Heart Failure in the United States: Rising Burden and Unmet Needs

Heart failure (HF) affects nearly 1 in 4 Americans over their lifetime, and its growing prevalence, rising mortality, widening disparities, and persistent undertreatment have made it an increasingly urgent public health crisis. About one-third of U.S. adults without symptomatic HF are already at risk (Stage A), while another 24–34% have […]